$BriaCell Therapeutics (BCTX.US)$ Pending good news leak out ?

$BriaCell Therapeutics (BCTX.US)$
Something brewing ?

$BriaCell Therapeutics (BCTX.US)$ BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with "Eye-Bulging" Tumor
1 MINUTE AGO, 7:50 AM EDT
VIA GLOBENEWSWIRE
• Dramatic anti-tumor response includes complete resolution of right temporal lobe brain metastasis in patient with "Eye-Bulging" metastatic breast cancer
• Heavily pre-treated patient had failed 8 prior regimens including antibody-drugconjugate (ADC) therapy and continues to receive BriaCell treatment

$BriaCell Therapeutics (BCTX.US)$
BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with "Eye-Bulging" Tumor
Dramatic anti-tumor response includes complete resolution of right temporal lobe brain metastasis in patient with "Eye-Bulging" metastatic breast cancer
Heavily pre-treated patient had failed 8 prior regimens including antibody-drug conjugate (ADC) therapy and continues to receive BriaCell treatment
PHILADELPHIA and VANCOUVER, British Columbia, Oct. 01, 2024...

$BriaCell Therapeutics (BCTX.US)$
buy and hold....till the next above 1 dollar comes. cause its worth.

$BriaCell Therapeutics (BCTX.US)$ offerinng of common shares, 12.32mil common shares and offering price of 0.69 per share

$Annovis Bio (ANVS.US)$ Annovis Bio (NYSE:ANVS) said the Data and Safety Monitoring Board has issued a positive recommendation for its Phase 2/3 study of its drug buntanetap in the treatment of mild-to-moderate Alzheimer’s disease.
Annovis said the board found no drug-related Serious Adverse Events, and an Adverse Event rate of less than 5%. The dropout rate for the study was 4.7%.
The company started the study in late March 2023.